A multi-organ analysis of the role of mTOR in fetal alcohol spectrum disorders

FASEB J. 2023 May;37(5):e22897. doi: 10.1096/fj.202201865R.

Abstract

Alcohol exposure during gestation can lead to fetal alcohol spectrum disorders (FASD), an array of cognitive and physical developmental impairments. Over the past two and a half decades, Mammalian Target of Rapamycin (mTOR) has emerged at the nexus of many fields of study, and has recently been implicated in FASD etiology. mTOR plays an integral role in modulating anabolic and catabolic activities, including protein synthesis and autophagy. These processes are vital for proper development and can have long lasting effects following alcohol exposure, such as impaired hippocampal and synapse formation, reduced brain size, as well as cognitive, behavioral, and memory impairments. We highlight recent advances in the field of FASD, primarily with regard to animal model discoveries and discuss the interaction between alcohol and mTOR in the context of various tissues, including brain, placenta, bone, and muscle, with respect to developmental alcohol exposure paradigms. The current review focuses on novel FASD research within the context of the mTOR signaling and sheds light on mechanistic etiologies at various biological levels including molecular, cellular, and functional, across multiple stages of development and illuminates the dichotomy between the different mTOR complexes and their unique signaling roles.

Keywords: alcohol; autophagy; development; fetal; mTOR; pregnancy.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Brain / metabolism
  • Disease Models, Animal
  • Ethanol / toxicity
  • Female
  • Fetal Alcohol Spectrum Disorders* / etiology
  • Humans
  • Mammals / metabolism
  • Pregnancy
  • Prenatal Exposure Delayed Effects* / metabolism
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Ethanol
  • TOR Serine-Threonine Kinases
  • MTOR protein, human